| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 457.37 | 86.32 | 0.35 | 0.19 |
| Accumulated Depreciation Total | -2.84 | - | - | - |
| Other Liabilities Total | 0.09 | - | - | - |
| Accrued Expenses | 0.29 | - | - | - |
| Long Term Debt | 0.26 | 0.00 | 0.00 | 0.00 |
| Common Stock Total | 63.80 | 53.50 | 0.17 | 0.17 |
| Other Equity Total | -0.22 | - | - | - |
| Other Current Assets Total | 0.40 | 2.06 | 0.04 | 0.01 |
| Prepaid Expenses | 0.21 | - | - | - |
| Total Assets | 457.37 | 86.32 | 0.35 | 0.19 |
| Current Portof LT Debt/ Capital Leases | 8.03 | 0.43 | - | - |
| Additional Paid- In Capital | 240.82 | - | - | - |
| Cash | 104.26 | - | - | - |
| Total Equity | 337.52 | 81.11 | -0.27 | -0.23 |
| Long Term Investments | 10.77 | 1.21 | - | - |
| Retained Earnings( Accumulated Deficit) | 33.13 | 27.61 | -0.44 | -0.40 |
| Total Common Shares Outstanding | 63.80 | 53.50 | 0.17 | 0.17 |
| Property/ Plant/ Equipment Total- Gross | 22.56 | - | - | - |
| Tangible Book Valueper Share Common Eq | 5.21 | 1.47 | -1.55 | -1.33 |
| Goodwill Net | 5.28 | 2.22 | - | - |
| Total Liabilities | 119.85 | 5.21 | 0.62 | 0.42 |
| Total Debt | 85.37 | 1.68 | 0.57 | 0.39 |
| Short Term Investments | 147.09 | 40.05 | 0.01 | 0.03 |
| Cashand Short Term Investments | 251.36 | 41.00 | 0.04 | 0.04 |
| Total Receivables Net | 104.16 | 22.87 | 0.17 | - |
| Notes Payable/ Short Term Debt | 60.14 | 0.00 | 0.57 | 0.39 |
| Deferred Income Tax | 0.39 | 0.12 | - | - |
| Accounts Receivable- Trade Net | 76.18 | 22.87 | 0.17 | - |
| Property/ Plant/ Equipment Total- Net | 19.72 | 12.49 | - | - |
| Minority Interest | 0.34 | - | - | - |
| Total Current Liabilities | 101.82 | 3.83 | 0.62 | 0.42 |
| Total Inventory | 9.16 | 4.48 | - | - |
| Accounts Payable | 20.65 | 2.16 | 0.01 | 0.01 |
| Other Currentliabilities Total | 12.71 | 1.25 | 0.03 | 0.02 |
| Total Long Term Debt | 17.21 | 1.25 | 0.00 | 0.00 |
| Other Long Term Assets Total | 17.73 | 0.00 | 0.11 | 0.14 |
| Note Receivable- Long Term | 38.59 | - | - | - |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 365.29 | 70.41 | 0.25 | 0.05 |
| Capital Lease Obligations | 16.94 | 1.25 | - | - |
| Cash Equivalents | - | 0.95 | 0.04 | 0.02 |
Fischer Medical Ventures Dividend Fischer Medical Ventures Bonus Fischer Medical Ventures News Fischer Medical Ventures AGM Fischer Medical Ventures Rights Fischer Medical Ventures Splits Fischer Medical Ventures Board Meetings Fischer Medical Ventures Key Metrics Fischer Medical Ventures Shareholdings Fischer Medical Ventures Profit Loss Fischer Medical Ventures Cashflow Fischer Medical Ventures Q1 Results Fischer Medical Ventures Q2 Results Fischer Medical Ventures Q3 Results Fischer Medical Ventures Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks